C4 (CCCC) Climbs 11.97% on August 5

Equities Staff  |

C4 Therapeutics Inc (NASDAQ: CCCC) has gained $1.31 (11.97%) and is currently sitting at $11.98, as of 11:50:34 est on August 5.

256,698 shares have traded hands.

The Company has increased 17.47% over the last 5 days and shares have risen 34.02% over the last 30 days.

C4 expects its next earnings on 2022-08-10.

For technical charts, analysis, and more on C4 visit the company profile.

About C4 Therapeutics Inc

C4 Therapeutics is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer and other diseases. This targeted protein degradation approach offers advantages over traditional therapies, including the potential to treat a wider range of diseases, reduce drug resistance, achieve higher potency, and decrease side effects through greater selectivity.

To get more information on C4 Therapeutics Inc and to follow the company's latest updates, you can visit the company's profile page here: C4 Therapeutics Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Trending Articles

China, Taiwan and the Boycott
An Easy Way to Profit Off One of Today’s Strongest Sectors
The Future of Smartphones is Still Unfolding: Jeff Kagan
These Stocks are Sending a Signal (Like Amazon in 2008)
It Isn’t a Recession Until This Group of Economists Says So
What You Should Know About Europe's Energy Wars
Meatless Meats and Smokeless Smokes
Mixed Wireless Recovery at AT&T, Verizon, T-Mobile: Jeff Kagan

Market Movers

Sponsored Financial Content